SSII
SS Innovations International, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$3.41
+0.59%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 52.4M | 42.5M | 20.6M | 5.9M | 1.5M |
| Cost of Revenue | 27.8M | 22.9M | 12.2M | 5.2M | 968.7K |
| Gross Profit | 24.6M | 19.5M | 8.5M | 713.4K | 489.6K |
| Operating Expenses | |||||
| R&D Expense | 5.6M | 3.7M | 2.5M | 576.2K | 83.3K |
| SG&A Expense | 24.4M | 23.0M | 24.5M | 20.8M | 6.1M |
| General & Admin Expense | 16.8M | 23.0M | 24.5M | 20.8M | 6.1M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 3.1M | 1.1M | 436.0K | — | — |
| Total Operating Expenses | 33.1M | 27.7M | 27.4M | 21.4M | 6.2M |
| Cost and Expenses | 60.9M | 50.7M | 39.6M | 26.5M | 7.1M |
| Operating Income (EBIT) | (8.5M) | (8.2M) | (19.0M) | (20.7M) | (5.7M) |
| Non-Operating | |||||
| Interest Income | 1.5M | 1.1M | 798.0K | 129.8K | 239.7K |
| Interest Expense | 1.1M | 1.1M | 973.2K | 523.4K | 162.0K |
| Net Interest Income | 316.5K | 33.1K | (175.2K) | (393.6K) | 77.7K |
| Other Non-Op Income/Expense | 333.5K | 33.1K | (175.2K) | (273.6K) | 77.7K |
| Non-Operating Income (excl Interest) | (1.0M) | (1.1M) | (798.0K) | (249.8K) | (239.7K) |
| EBT (Pre-Tax Income) | (8.2M) | (8.2M) | (19.2M) | (20.9M) | (5.6M) |
| Income Tax Expense | 4.3M | 4.0M | — | — | — |
| Bottom Line | |||||
| Net Income | (12.4M) | (12.1M) | (19.2M) | (20.9M) | (5.6M) |
| Earnings from Cont. Ops | (12.4M) | (12.1M) | (19.2M) | (20.9M) | (5.6M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (12.4M) | (12.1M) | (19.2M) | (20.9M) | (5.6M) |
| Per Share | |||||
| Basic EPS | ($0.07) | ($0.06) | ($0.11) | ($0.16) | ($1.41) |
| Diluted EPS | ($0.07) | ($0.06) | ($0.10) | ($0.16) | ($1.41) |
| Revenue Per Share | $0.26 | $0.22 | $0.12 | $0.05 | $0.37 |
| Shares | |||||
| Basic Shares Outstanding | 200.1M | 190.0M | 170.8M | 128.4M | 4.0M |
| Diluted Shares Outstanding | 209.4M | 198.7M | 181.9M | 128.4M | 4.0M |
| Profitability Metrics | |||||
| EBITDA | (6.2M) | (6.0M) | (17.7M) | (20.3M) | (5.3M) |
| D&A | 1.3M | 1.1M | 436.0K | 162.6K | 128.9K |
| EBIT | (7.5M) | (7.1M) | (18.2M) | (20.4M) | (5.4M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026